Juliette Haudebourg

Papers

Total Citations

H-Index

About

Juliette Haudebourg is a radiation oncologist whose work centers on advancing stereotactic radiotherapy techniques for early-stage breast cancer. Her most notable contribution is the Phase 2 trial "Robotic Stereotactic Boost in Early Breast Cancer," which investigated the feasibility and safety of delivering a precise, high-dose radiation boost using robotic stereotactic technology. This study, though early in its citation impact (3 citations), represents a critical step toward refining treatment protocols that minimize damage to healthy tissue while maximizing tumor control. Haudebourg’s research sits at the intersection of precision oncology and surgical robotics, aiming to improve outcomes for patients with localized disease. Her work underscores the growing role of non-invasive, image-guided approaches in breast cancer management, offering a potential alternative to traditional whole-breast irradiation. As a clinician-scientist, she contributes to the broader effort to personalize radiotherapy, reducing side effects and enhancing quality of life. Her ongoing investigations continue to shape how robotic systems are integrated into standard care, marking her as a promising voice in the evolution of stereotactic body radiation therapy.